Compounds > 1-nitrohydroxyphenyl-n-benzoylalanine
Page last updated: 2024-09-05

1-nitrohydroxyphenyl-n-benzoylalanine and Carcinoma, Small Cell Lung

1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with Carcinoma, Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baños, N; Cebrián, A; Cedeño, M; Corral, JM; Dómine, M; Galeano, C; García-Foncillas, J; Mahillo-Fernández, I; Puerto-Nevado, LD; Río-Vilariño, A1

Other Studies

1 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and Carcinoma, Small Cell Lung

ArticleYear
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Benzamides; Galectin 1; Humans; Lung Neoplasms; Small Cell Lung Carcinoma

2022